Insufficient scRNA-seq data for expression of RAET1E at single-cell level.
Insufficient scRNA-seq data for expression of RAET1E at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 91% | 837.04 | 1644 / 1809 | 7% | 0.26 | 32 / 472 |
esophagus | 40% | 1311.65 | 576 / 1445 | 34% | 1.69 | 62 / 183 |
kidney | 72% | 152.94 | 64 / 89 | 2% | 0.05 | 16 / 901 |
bladder | 33% | 64.10 | 7 / 21 | 39% | 1.81 | 198 / 504 |
tonsil | 0% | 0 | 0 / 0 | 64% | 3.73 | 29 / 45 |
spleen | 59% | 65.19 | 143 / 241 | 0% | 0 | 0 / 0 |
uterus | 4% | 51.70 | 6 / 170 | 52% | 3.00 | 238 / 459 |
adrenal gland | 38% | 43.56 | 97 / 258 | 17% | 1.28 | 38 / 230 |
breast | 23% | 24.01 | 105 / 459 | 25% | 0.68 | 281 / 1118 |
adipose | 41% | 145.45 | 491 / 1204 | 0% | 0 | 0 / 0 |
lung | 9% | 12.97 | 52 / 578 | 21% | 0.67 | 243 / 1155 |
muscle | 30% | 61.58 | 241 / 803 | 0% | 0 | 0 / 0 |
thymus | 6% | 4.87 | 36 / 653 | 24% | 0.60 | 148 / 605 |
intestine | 0% | 0.36 | 4 / 966 | 8% | 0.21 | 44 / 527 |
blood vessel | 6% | 7.11 | 85 / 1335 | 0% | 0 | 0 / 0 |
heart | 6% | 8.42 | 51 / 861 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0.36 | 1 / 328 | 6% | 0.10 | 10 / 178 |
prostate | 3% | 4.55 | 7 / 245 | 1% | 0.02 | 7 / 502 |
stomach | 1% | 3.06 | 3 / 359 | 3% | 0.07 | 9 / 286 |
liver | 0% | 0 | 0 / 226 | 1% | 0.01 | 3 / 406 |
brain | 0% | 0.42 | 12 / 2642 | 0% | 0.01 | 1 / 705 |
ovary | 1% | 0.43 | 1 / 180 | 0% | 0 | 0 / 430 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0045954 | Biological process | positive regulation of natural killer cell mediated cytotoxicity |
GO_0002476 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class Ib |
GO_0002486 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent |
GO_0001916 | Biological process | positive regulation of T cell mediated cytotoxicity |
GO_0042267 | Biological process | natural killer cell mediated cytotoxicity |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
GO_0046703 | Molecular function | natural killer cell lectin-like receptor binding |
Gene name | RAET1E |
Protein name | Retinoic acid early transcript 1E Retinoic acid early transcript 1E (Lymphocyte effector toxicity activation ligand) (NKG2D ligand 4) (N2DL-4) (NKG2DL4) (RAE-1-like transcript 4) (UL16-binding protein 4) RAET1E RAET1E (ULBP4) NKG2D ligand (RAET1E) RAET1E protein (Retinoic acid early transcript 1E) |
Synonyms | LETAL ULBP4 N2DL4 RAET-1E UNQ1867/PRO4303 |
Description | FUNCTION: Binds and activates the KLRK1/NKG2D receptor, mediating natural killer cell cytotoxicity. . |
Accessions | ENST00000357183.9 [Q8TD07-1] Q3T1D4 I2GUA3 Q3ZAR2 ENST00000532335.5 [Q8TD07-3] A0A0G3VUT9 ENST00000529948.1 [Q8TD07-4] I2GUA6 I2GUA5 A0A060ILJ5 A0A0G3VRR7 I2GUA2 A0A0G3VTM3 I2GUA4 A0A0G3VTN0 A0A0G3VTF2 A0A0G3VTF8 A0A0G3VSE5 I7EC85 ENST00000392270.3 Q8TD07 ENST00000367363.3 [Q8TD07-2] A0A0G3VTF5 I7FHP4 |